Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Galapagos reports progress for CF drug

Country: Belgium

A new small molecule drug intended to treat cystic fibrosis patients with the F508del gene mutation has been well tolerated in patients in a Phase 2 study, paving the way for its use as part of a triple therapy, Galapagos NV announced on 19 November.

Read more

Amsterdam to be new home for EMA

Country: Belgium

Amsterdam is to be the new home for the European Medicines Agency following Britain’s decision to leave the European Union, and give up its right to host EU institutions at the end of March 2019. The decision was announced on 20 November by the EU General Affairs Council.

Read more

Roche has two Phase 3 successes

Country: Switzerland

Read more

New FDA guidance for cells, tissues

Country: United States

Read more

Ablynx provides nine-month update

Country: Belgium

Read more

Partnership seeks in vivo gene editing

Country: Switzerland

Read more

New drug for CMV after transplants

Country: United Kingdom

Read more

Roche MS drug recommended by EMA

Country: United Kingdom

Read more

Patrick Vallance to become UK chief scientific adviser

Country: United Kingdom

Read more

Higher operating profit at AZ

Country: United Kingdom

Read more

Lundbeck results disappoint, management in transition

Country: Denmark

Read more

Evotec grows in Q3 but profit slips

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Assessing the threat from drug-resistant bacteria by Jennifer Schneider

AntibioticReviewJennifer SchneiderOct2017.pdf

Highlights of the October 2017 MedNous issue

The October 2017 MedNous features:

Latest Mednous cover
  • Business Strategy
    Detecting cancer
    using liquid biopsy
  • Antibiotic Review
    Assessing the threat from
    drug-resistant bacteria
    By Jennifer Schneider
  • Research Strategy
    Building multifunctional
    biologics to treat disease
    By Brian McGuinness and
    Peter Pack
  • Regenerative Medicine
    Regulatory challenges for
    cell therapy manufacture
    By Adeyemi Afuwape and Tim Farries
  • Biotech Financing
    Underinvested Europe has boost,
    but Nasdaq calls

The latest MedNous journal. Subscribe to download.